Impact of 23-valent pneumococcal polysaccharide vaccination on the frequency of pneumonia-related hospitalization and survival in elderly patients with prostate cancer: A seven-year nationwide matched cohort study.

Chung-Yi LiLiang-Cheng ChenHon-Yi LinMoon-Sing LeeShih-Kai HungChun-Liang LaiLi-Wen HuangBen-Hui YuFeng-Chun HsuWen-Yen Chiou

Published in: Cancer (2020)

Vaccination of elderly patients who have prostate cancer with the relatively common and inexpensive PPSV23 can decrease the risk of pneumonia and prolong survival.

Keyphrases

prostate cancer
radical prostatectomy
free survival
respiratory failure
community acquired pneumonia
extracorporeal membrane oxygenation
drug induced
water soluble